What is the Difference Between Transverse Myelitis and Guillain Barre Syndrome?
🆚 Go to Comparative Table 🆚Transverse myelitis (TM) and Guillain-Barré syndrome (GBS) are both immunologically mediated polyneuropathies, but they have distinct differences in their clinical manifestations and characteristics.
Transverse Myelitis:
- Characterized by acute or subacute motor, sensory, and autonomic spinal cord dysfunction.
- Inflammatory disorder affecting the spinal cord.
- Clinical signs are caused by an immune-mediated process.
- Incidence of 1 to 8 new cases per million per year.
Guillain-Barré Syndrome:
- Characterized by progressive weakness, autonomic dysfunction, and pain.
- Acute inflammatory immune-mediated polyradiculoneuropathy.
- Immune injury specifically takes place at the myelin sheath.
- Incidence of 1 to 4 new cases per 100,000 per year.
Both conditions are thought to have a genetic predisposition and are considered autoimmune, although their etiologies remain enigmatic. They can be triggered by infectious agents and vaccines, and both can be diagnosed through nerve conduction tests and treated through immunotherapies.
Comparative Table: Transverse Myelitis vs Guillain Barre Syndrome
Here is a table comparing the differences between Transverse Myelitis (TM) and Guillain-Barré Syndrome (GBS):
Feature | Transverse Myelitis (TM) | Guillain-Barré Syndrome (GBS) |
---|---|---|
Definition | TM is an inflammatory disorder characterized by acute or subacute motor, sensory, and autonomic spinal cord dysfunction. | GBS is a form of paralysis caused by inflammation of the peripheral nerves. |
Neuro-inflammation | Inflammation: The clinical signs are caused by an inflammatory disorder. | Inflammation: Perinodal and/or patchy demyelination, perivascular focal lymphocytic infiltration of T cells, myelin swelling, and the presence of macrophages within the nerve fibers are typical findings in GBS. |
Symptoms | Sensory, motor, and autonomic dysfunctions as a result of immune-mediated spinal cord injury. | Symptoms include: weakness, paralysis, and sensory abnormalities, such as numbness, tingling, and pain. |
Causes | TM is thought to have a genetic predisposition and may be induced via molecular mimicry. | GBS is thought to have a genetic predisposition and has an unknown etiology in a substantial portion of cases. |
Treatment | Treatment for TM is not well defined in the provided search results. | Treatment for GBS may include intravenous immunoglobulin or plasmapheresis. |
Both TM and GBS are immunologically mediated polyneuropathies of major clinical importance, and both are considered autoimmune, but their etiologies remain enigmatic.
- Guillain Barre Syndrome vs Myasthenia Gravis
- Polio vs Guillain Barre Syndrome
- Muscular Dystrophy vs Myasthenia Gravis
- Myasthenia Gravis vs Lambert Eaton Myasthenic Syndrome
- Myasthenia Gravis vs Lambert Eaton Syndrome
- Multiple Sclerosis vs Motor Neuron Disease
- Multiple Sclerosis vs Systemic Sclerosis
- Polymyositis vs Polymyalgia Rheumatica
- MGUS vs Multiple Myeloma
- Syringomyelia vs Syringobulbia
- ALS vs MS (Multiple Sclerosis)
- Myeloma vs Multiple Myeloma
- Multiple Sclerosis vs Rheumatoid Arthritis
- Fibromyalgia vs MS
- Cervical Radiculopathy vs Myelopathy
- Myositis vs Rhabdomyolysis
- Muscular Dystrophy vs Myotonic Dystrophy
- Dermatomyositis vs Polymyositis
- Parkinson’s vs Myasthenia Gravis